ResultsIQ

ResultsIQ › Latest results › Park Medi World Limited

Park Medi World Limited Q1 FY27 results press release summary

NSE: PARKHOSPS · BSE: 544645

Results press release of 3 Aug 2026, summarised by AI from the filing.

Management expects to commission 1,490 beds in calendar year 2026, c.46% growth over 2025 capacity of 3,250 beds.

Key takeaways

  1. Capacity guidance Management expects to commission 1,490 beds in calendar year 2026, c.46% growth over 2025 capacity of 3,250 beds.
  2. Growth driver Largest capacity expansion in company history, with newly commissioned beds still ramping up.
  3. Risk Near-term focus on integration of acquired assets and improving utilisation at newer facilities.

Original filing on BSE

Park Medi World Limited Q1 FY27 results

As filed: Revenue ₹476 cr, EBITDA ₹126 cr, PAT ₹88.6 cr, EBITDA margin 26.5%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹476 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹460 cr, EBITDA ₹127 cr, PAT ₹76.8 cr, EBITDA margin 27.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹460 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +5.2% in 30 days (Nifty 500: −3.0%).
  • Q3 FY26: Revenue ₹410 cr, EBITDA ₹99.4 cr, PAT ₹52.9 cr, EBITDA margin 24.3%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹410 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +29.5% in 30 days (Nifty 500: +1.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Park Medi World Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.